At present, there is a balance payers must achieve across a variety of influencing factors on whether to cover GLP-1s (see Figure 1)
Your healthcare provider or a registered dietitian can help determine the right targets for your body and your pace of weight loss
Its about hormones, stress, neural pathways, lifestyle, and how all of it connects
When hair loss on retatrutide is NOT telogen effluvium Not all hair loss during retatrutide treatment is benign telogen effluvium
Reviewing your current coverage and potentially discussing expanded coverage during enrollment periods could improve your access when Retatrutide launches
It rose gradually during the dose-escalation phase, peaked around week 24, and then declined at weeks 36 and 48 even though participants continued taking the same dose